T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Snapshot
Quick Stats
Current NAV as of 06/18/2013 $50.25
NAV Change $0.41
Daily YTD Return as of 06/18/2013 21.91%
NAV 12 Month Low-High $39.08 - $51.07
Net Assets as of 04/30/2013 $6,514.87 Million
Morningstar Ratings1
as of 04/30/2013
Overall
3 Year
5 Year
10 Year
Morningstar rated the Health Sciences Fund among 129, 129, 119 and 98 Health funds for the overall rating and the 3-, 5-, and 10-year periods (as applicable) ending 04/30/2013, respectively. Morningstar Ratings™ are based on risk-adjusted returns. The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund's 3-, 5-, and 10-year (if applicable) Morningstar Rating™ metrics.
Performance Comparison
as of 04/30/2013
This chart shows the value of a hypothetical $10,000 investment in the fund over the past 10 years or since its inception (for funds lacking 10-year records). The result is compared with benchmarks, which may include a broad-based market index and a peer group average or index. Market indexes do not include expenses, which are deducted from fund returns as well as mutual fund averages and indexes.
Benchmark Definitions
1 For funds with at least a 3-year history, a Morningstar Rating™ is based on a risk-adjusted return measure (including the effects of sales charges, loads, and redemption fees) with emphasis on downward variations and consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% 4 stars, the next 35% 3 stars, the next 22.5% 2 stars, and the bottom 10% 1 star. Each share class is counted as a fraction of 1 fund within this scale and rated separately. Morningstar Rating™ is for the retail share class only; other classes may have different performance characteristics.
©2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Average Annual Total Returns and Benchmarks
as of 03/31/2013
Benchmark Definitions
Investment Objective
The fund's objective is long-term capital appreciation.
Average Annual Total Returns2
  Month
End
05/31/2013 		Quarter
End
03/31/2013
1 Year 39.33% 28.77%
3 Years 27.96% 21.65%
5 Years 15.65% 15.87%
10 Years 14.41% 15.33%
Since Inception 13.82% 13.57%
Inception Date December 29, 1995
Expense Ratio as of 12/31/2012 0.79%
Current performance may be lower or higher than the quoted past performance, which cannot guarantee future results. Share price, principal value, and return will vary and you may have a gain or loss when you sell your shares.
2 Average annual total return figures include changes in principal value, reinvested dividends, and capital gain distributions. For funds less than one year old, the Since Inception return figure is not annualized and represents an aggregate total return.
See Glossary for additional details on all data elements.